Target intelligence / Profile preview

Mitochondrial electron transport chain and cellular antioxidant systems (ETC/AOS)

Target
ETC/AOS
Molecular classification
Enzyme, Protein complex, Oxidoreductase, Transporter
01

Overview

The mitochondrial electron transport chain (ETC) and cellular antioxidant systems constitute the primary machinery for cellular energy transduction and the maintenance of redox homeostasis. The ETC is composed of a series of protein complexes (I-IV) and electron carriers that facilitate oxidative phosphorylation to generate ATP, while the antioxidant systems—comprising enzymes like superoxide dismutase (SOD) and molecules like glutathione—protect the cell from the reactive oxygen species (ROS) generated during this process (StatPearls, 2023). Dysfunction in these systems is central to the pathogenesis of neurodegenerative diseases like Parkinson's, where mitochondrial failure leads to oxidative stress, and in cancer, where cells often rewire these pathways to survive in hypoxic environments (PubMed, 2021). Therapeutic strategies targeting this axis range from ETC inhibitors like metformin, which modulates Complex I, to mitochondrial-targeted antioxidants like MitoQ designed to reduce oxidative damage (NIH, 2022). Because these systems are fundamental to nearly all aerobic life, pharmacological intervention requires precise targeting to avoid systemic toxicity or the disruption of vital metabolic functions.

Other names
Mitochondrial respiratory chainOxidative phosphorylation systemRedox homeostasis systemMitochondrial oxidative machinery
02

Mechanism of action

Modulation of electron flow through respiratory complexes, scavenging of reactive oxygen species, enhancement of endogenous antioxidant enzyme activity, and uncoupling of oxidative phosphorylation.

03

Biological functions

ATP productionOxidative phosphorylationRedox regulationApoptosisReactive oxygen species (ROS) managementMetabolic signaling
04

Disease associations

Neurodegenerative diseaseCancerMitochondrial diseaseCardiovascular diseaseMetabolic syndromeAging-related disorders
05

Safety considerations

Lactic acidosisMitochondrial toxicitySystemic oxidative stressInterference with essential cellular respirationPotential for pro-oxidant effects at high doses
06

Interacting drugs

Metformin

9 more in the full profile.

07

Biomarkers

Lactate/Pyruvate ratioReactive oxygen species (ROS) levelsGlutathione (GSH/GSSG) ratioMitochondrial membrane potential (ΔΨm)Oxygen consumption rate (OCR)8-hydroxy-2-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Mitochondrial electron transport chain and cellular antioxidant systems (ETC/AOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial electron transport chain and cellular antioxidant systems (ETC/AOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call